PHARMACYTE BIOTECH, INC. (PMCB) earnings per share
Annual history
Fiscal years 2012 – 2025
USD / SHARE 9 PERIODS
| Period | End | Diluted | Filed |
|---|---|---|---|
| FY 2025 | 2025-04-30 | $3.19 | 2025-08-11 |
| FY 2024 | 2024-04-30 | -$1.80 | 2024-08-13 |
| FY 2023 | 2023-04-30 | -$0.22 | 2023-07-31 |
| FY 2022 | 2022-04-30 | -$0.27 | 2022-07-28 |
| FY 2021 | 2021-04-30 | -$2.45 | 2021-08-10 |
| FY 2014 | 2014-04-30 | — | 2014-08-04 |
| FY 2013 | 2013-04-30 | — | 2013-07-29 |
| FY 2012 | 2012-04-30 | — | 2012-08-14 |
| FY 2012 | 2011-04-30 | — | 2012-08-14 |
Quarterly history
Fiscal years 2012 – 2026
USD / SHARE 38 PERIODS
| Period | End | Diluted | Filed |
|---|---|---|---|
| Q3 2026 | 2026-01-31 | -$0.17 | 2026-03-17 |
| Q2 2026 | 2025-10-31 | -$1.24 | 2025-12-18 |
| Q1 2026 | 2025-07-31 | -$1.23 | 2025-09-15 |
| Q4 2025 | 2025-04-30 | $1.52 | 2025-08-11 |
| Q3 2025 | 2025-01-31 | -$0.44 | 2025-03-17 |
| Q2 2025 | 2024-10-31 | -$0.39 | 2024-12-13 |
| Q1 2025 | 2024-07-31 | $1.90 | 2024-09-17 |
| Q4 2024 | 2024-04-30 | -$0.33 | 2024-08-13 |
| Q3 2024 | 2024-01-31 | -$0.65 | 2024-03-18 |
| Q2 2024 | 2023-10-31 | -$0.26 | 2023-12-15 |
| Q1 2024 | 2023-07-31 | -$0.54 | 2023-09-18 |
| Q4 2023 | 2023-04-30 | -$0.01 | 2023-07-31 |
| Q3 2023 | 2023-01-31 | -$0.04 | 2023-03-16 |
| Q2 2022 | 2022-10-31 | -$0.09 | 2022-12-14 |
| Q1 2023 | 2022-07-31 | -$0.07 | 2022-09-14 |
| Q4 2022 | 2022-04-30 | -$0.06 | 2022-07-28 |
| Q3 2022 | 2022-01-31 | -$0.04 | 2022-03-15 |
| Q2 2022 | 2021-10-31 | -$0.06 | 2021-12-14 |
| Q1 2022 | 2021-07-31 | -$0.64 | 2021-09-14 |
| Q3 2015 | 2015-01-31 | — | 2015-03-13 |
| Q2 2015 | 2014-10-31 | — | 2014-12-15 |
| Q1 2015 | 2014-07-31 | — | 2014-09-15 |
| Q4 2014 | 2014-04-30 | — | 2014-08-04 |
| Q3 2014 | 2014-01-31 | — | 2014-03-17 |
| Q2 2014 | 2013-10-31 | — | 2013-12-16 |
| Q1 2014 | 2013-07-31 | — | 2013-09-16 |
| Q4 2013 | 2013-04-30 | — | 2013-07-29 |
| Q3 2013 | 2013-01-31 | — | 2013-03-26 |
| Q2 2013 | 2012-10-31 | — | 2012-12-26 |
| Q1 2013 | 2012-07-31 | — | 2012-09-19 |
| Q4 2012 | 2012-04-30 | — | 2012-08-14 |
| Q3 2012 | 2012-01-31 | — | 2012-03-21 |
| Q2 2012 | 2011-10-31 | — | 2011-12-15 |
| Q1 2012 | 2011-07-31 | — | 2011-09-20 |
| Q4 2012 | 2011-04-30 | — | 2012-08-14 |
| Q3 2012 | 2011-01-31 | — | 2012-03-21 |
| Q2 2012 | 2010-10-31 | — | 2011-12-15 |
| Q1 2012 | 2010-07-31 | — | 2011-09-20 |
Methodology
Annual rows come from the filer's 10-K and Q1–Q3 rows from the matching 10-Q; Q4 is derived as full-year minus nine-month YTD because XBRL doesn't tag Q4 as its own period. EPS Basic and EPS Diluted are reported directly by the filer. Per-share values are split-adjusted to the current share count (2 split s since 2003).
For the exact XBRL concepts and formulas, see the methodology reference for EPS, FCF per share, the Q4 derivation, and split adjustment.
PMCB CIK 0001157075 Source: EDGAR filings · all facts